Fundraising FoxHorizon Pharma
Deerfield, US · Founded 2010 · 1 known investors
Find your way into Horizon Pharma
Founders & leadership
TP
Timothy P. WalbertExecutive
RD
Robert De VaereExecutive
Board
JW
Jeffrey W. BirdBoard director
LC
JH
Jeff HimawanBoard director
JF
Jean-Francois FormelaBoard director
MG
Michael GreyBoard director
RP
Ronald PauliBoard director
GS
Gino SantiniBoard director
Investors · 1
Scale Venture PartnersreportedSan Francisco · $5M – $25M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$66M disclosed across 2 rounds · 2012
▶$65.9MraisedMar 2012 · 32 investors · PharmaceuticalsRule 506(b)
▶$65.9MraisedMar 2012 · 32 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Timothy P. WalbertExecutive Officer, Director
- Jean-Francois FormelaDirector
- Jeffrey W. BirdDirector
- Jeff HimawanDirector
- Louis C. BockDirector
- Gino SantiniDirector
- Ronald PauliDirector
- Michael GreyDirector
- Robert De VaereExecutive Officer
- Offering amount
- $65.9M
- Amount sold
- $65.9M
- Sales commissions
- $3.1M
- Placement agents
- Stifel, Nicolaus & Company Incorporated, JMP Securities, LLC, Cowen & Company LLC
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
▶$32.8KraisedMar 2012 · 6 investors · PharmaceuticalsRule 506(b)
▶$32.8KraisedMar 2012 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael GreyDirector
- Ronald PauliDirector
- Jeffrey W. BirdDirector
- Louis C. BockDirector
- Timothy P. WalbertExecutive Officer, Director
- Jeff HimawanDirector
- Gino SantiniDirector
- Robert De VaereExecutive Officer
- Jean-Francois FormelaDirector
- Offering amount
- $32.8K
- Amount sold
- $32.8K
- Sales commissions
- $3M
- Placement agents
- Cowen & Company LLC, JMP Securities, LLC, Stifel, Nicolaus & Company Incorporated
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Acquisitions · 1
Early investors' stakes continue via these dealsRaptor Pharmaceuticals
Raptor Pharmaceutical Corp. was a Novato, California biopharmaceutical company that developed treatments for rare diseases, including PROCYSBI for cystinosis and QUINSAIR for cystic fibrosis-related lung infections.
Frequently asked questions
- Who are Horizon Pharma's investors?
- Horizon Pharma's investors include Scale Venture Partners.
- How much funding has Horizon Pharma raised?
- Horizon Pharma has disclosed $66M raised across 2 rounds.
- Where is Horizon Pharma headquartered?
- Horizon Pharma is headquartered in Deerfield, US.